-
Cancer Immunotherapy Market Set to Witness Significant Growth by 2025-2032: Bristol-Myers Squibb Company, Pfizer Inc
25 Jun 2025 08:19 GMT
… & Johnson, Actym Therapeutics, Inc., Bristol-Myers Squibb Company, Pfizer Inc, Novartis AG … scope and have 450+ seasoned consultants, analysts, and researchers across 26 …
-
<![CDATA[Maintenance Tucatinib/HP Improves PFS Post 2-Year Mark in HER2+ mBC]]>
18 Dec 2025 16:53 GMT
… .
Disclosures: Hamilton disclosed being a consultant/;Advisor for: Pfizer Inc … , Prelude Therapeutics, ProfoundBio, Cullinan Oncology, Bristol-Myers Squibb, Eisai, Fochon Pharmaceuticals, Gilead Sciences, …
-
How the AI boom is leaving consultants behind
08 Sep 2025 21:28 GMT
… created real business value.
Sometimes consultants built successful proof of concepts … officer at Bristol-Myers Squibb.
“If I were to go hire a consultant to … Catalant, a platform for freelance consultants.
Consultants also are contending with the …
-
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
17 Dec 2025 18:00 GMT
… Eli Lilly and Company, Merck, Bristol-Myers Squibb, Roche, Shanghai Henlius Biotech, … , Allogene Therapeutics, Xynomic Pharmaceuticals, Bristol-Myers Squibb, Incyte Corporation, among others. … is a leading Business Consultant, and Market Research firm …
-
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight
16 Dec 2025 01:05 GMT
… key dilated cardiomyopathy companies, including Bristol-Myers Squibb, Berlin Cures, Cumberland Pharmaceutical, Rocket …
DelveInsight is a leading Business Consultant and Market Research firm focused …
-
Car T Cell Therapy Market Investment Opportunities: A Guide to 2031 | Bristol-Myers Squibb Company, Novartis AG
09 Jan 2025 08:02 GMT
… players Highlighted in This Report:
• Bristol-Myers Squibb Company
• Johnson & Johnson Services … the U.S. and sales consultants in United Kingdom and Japan …
-
Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo 'Subcu' Approval
30 Dec 2024 19:45 GMT
Summary
Bristol-Myers Squibb stock has rebounded strongly in … and early July this year, Bristol-Myers Squibb's (
If you like …
Edmund Ingham is a biotech consultant. He has been covering biotech …
-
Molecular Diagnostics for Cancer Market Forecasts to 2030 with Executive and Consultant Guides - ResearchAndMarkets.com
16 Jun 2025 17:17 GMT
… and Place with Executive and Consultant Guides" has been added …
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction …
6.32 Bioview
6.33 Bristol-Myers Squibb
6.34 Burning Rock
6 …
-
Companion Diagnostic Markets Report 2025-2029: The Future of Diagnostics by Application, Technology and Funding with Executive & Consultant Guides - ResearchAndMarkets.com
06 Jun 2025 13:19 GMT
… and Funding with Executive & Consultant Guides" report has been …
1.3 Guide for Management Consultants and Investment Advisors
1.4 …
6.34 Bioview
6.35 Bristol-Myers Squibb
6.36 Burning Rock
6 …
-
Genomic Cancer Panel and Profiling Market Research Report 2025-2029 with Executive & Consultant Guides - ResearchAndMarkets.com
28 May 2025 15:03 GMT
… Market Size, Featuring Executive & Consultant Guides" report has been …
1.4 Guide for Management Consultants and Investment Advisors
1.5 …
6.30 Bioview
6.31 Bristol-Myers Squibb
6.32 Burning Rock
6 …
About
© 1995-2025